Loading
Latest filing published 01 Nov 2013 for MARIZYME, INC., €26k.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by John A. Moore Jr. span 3 companies, the busiest being Horne International, Inc., Paradigm Holdings, Inc and Marizyme, Inc. Over a trading history stretching from 21 November 2006 to 16 October 2013, the count stands at 17 filings.
Market trades split into 6 purchases (€290k) and 7 sales (€12k). Taken together, the purchases exceed the sales by €278k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. Since January 2013: 2 purchases and no sales on the market.
Half of the purchases are above €22k and half below.
The latest filing, published on 1 November 2013, reports an open-market purchase of €26k in Marizyme, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations